Pharmacom Financial Statements From 2010 to 2026

PHMB Stock  USD 0.0001  0.00  0.00%   
Pharmacom Biovet's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pharmacom Biovet's valuation are provided below:
Market Capitalization
1.1 M
We have found seventeen available trending fundamental ratios for Pharmacom Biovet, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Pharmacom Biovet recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Pharmacom Biovet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmacom Biovet's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 475.5 K or Total Revenue of 0.0, as well as many indicators such as . Pharmacom financial statements analysis is a perfect complement when working with Pharmacom Biovet Valuation or Volatility modules.
  
Build AI portfolio with Pharmacom Stock
Check out the analysis of Pharmacom Biovet Correlation against competitors.
For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.

Pharmacom Biovet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets135.7 K129.2 K108.4 K
Slightly volatile
Total Current Liabilities74.3 K70.8 K59.3 K
Slightly volatile
Total Stockholder Equity61.4 K58.4 K49.1 K
Slightly volatile
Accounts Payable74.3 K70.8 K59.3 K
Slightly volatile
Total Liabilities74.3 K70.8 K59.3 K
Slightly volatile
Intangible Assets3.6 KK4.4 K
Slightly volatile
Common Stock40.3 K37.5 K44.4 K
Slightly volatile
Property Plant Equipment86.3 K97.1 K106 K
Slightly volatile

Pharmacom Biovet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative475.5 K500.6 K1.6 M
Slightly volatile

Pharmacom Biovet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change To Netincome468.3 K492.9 K1.6 M
Slightly volatile
Change To Liabilities5.7 K9.8 K8.1 K
Pretty Stable

About Pharmacom Biovet Financial Statements

Pharmacom Biovet stakeholders use historical fundamental indicators, such as Pharmacom Biovet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pharmacom Biovet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharmacom Biovet's assets and liabilities are reflected in the revenues and expenses on Pharmacom Biovet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharmacom Biovet. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pharmacom Biovet offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pharmacom Biovet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pharmacom Biovet Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pharmacom Biovet Stock:
Check out the analysis of Pharmacom Biovet Correlation against competitors.
For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmacom Biovet. Anticipated expansion of Pharmacom directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pharmacom Biovet assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Pharmacom Biovet's market price often diverges from its book value, the accounting figure shown on Pharmacom's balance sheet. Smart investors calculate Pharmacom Biovet's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Pharmacom Biovet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Pharmacom Biovet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pharmacom Biovet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Pharmacom Biovet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.